Excluded
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
---
-Positive free-cash-flow history is shorter than two years.
C
HealthcareHealthcare PlansUS
Cigna Group (CI) Valuation Assumptions
Review Cigna Group (CI) valuation assumptions across intrinsic value, DCF, reverse DCF implied growth, EV/EBITDA, P/FCF, and financial trends.
US · US · USD
Latest price282.90 USD
30D+7.63%
Price vs model medianLimited model referenceModel median is the median base output from applicable absolute models, excluding Reverse DCF.
What price implies
Current price implied expectations
At 282.90 USD, the model implies roughly - annual FCF growth for 10 years, with required long-term operating margin near Assumption unavailable and terminal growth around 3%. This module is a research reference.
Implied FCF CAGR-
10-year Reverse DCF scenario
Required long-term operating marginAssumption unavailable
Five-year median × 0.95
Implied terminal growth3%
From current model assumptions
Discount rate assumption9%
Estimated from current sector rules
Valuation overview
Stock valuation context
Cigna Group (CI) valuation on TickerVal is designed to help readers understand the operating expectations embedded in the current market price. At 282.90 USD, the page brings intrinsic value analysis, DCF outputs, reverse DCF implied growth, EV/EBITDA, P/FCF, and valuation assumptions into one research view within the Healthcare sector and the Healthcare Plans industry. Instead of treating one model as a final answer, TickerVal compares cash-flow, earnings-power, balance-sheet, and relative-multiple lenses so the differences between models are visible. The reverse DCF view currently shows implied growth of not available, while the model median reference sits at a limited composite reference versus the current price. The DCF and reverse DCF sections focus on free cash flow, discount rate, terminal growth, and the long-term growth path implied by the current price. EV/EBITDA and P/FCF provide additional context for capital structure and cash-flow multiples. The financial trends section connects those valuation assumptions back to reported revenue of 275B USD, free cash flow of -, margins, and balance-sheet facts from public filings. Readers can use the layout to compare assumptions across models before reviewing the underlying source data. This page is intended for transparent research reference, model review, and assumption checking.
Valuation model range vs. current price
Each row shows a model output range, with a vertical line for the current price.
Earnings Power ValueCalculated
324.41 USD-324.41 USD
Graham NumberCalculated · Limited reference
278.41 USD-278.41 USD
Current price reference line
Why models disagree
Different models rely on different financial facts. The status blocks show which lenses fit this page data.
| Model | Fit | Context |
|---|---|---|
| DCF | Not meaningful | Useful when recurring free cash flow history exists; sensitive to growth and discount assumptions. |
| Owner Earnings | Not meaningful | Useful when net income, D&A, and capex support owner-earnings scenarios. |
| Reverse DCF | Not meaningful | Shows the FCF growth implied by current price under stated assumptions. |
| Earnings Power Value | Suitable | Useful for mature operating profit, with limited emphasis on growth. |
| Graham Number | Limited | Works best when EPS and book value are both positive. |
| Dividend Discount Model | Not meaningful | Needs explicit dividend history, which is not included in the current version. |
| Net-Net Liquidation Value | Not meaningful | Requires current asset and liability detail beyond the current data set. |
| PEG | Limited | A quick growth multiple lens when EPS history is positive. |
| EV/EBITDA | Limited | Useful for capital structure context when operating profit is available. |
| P/FCF | Not meaningful | A compact free-cash-flow multiple view for positive FCF years. |
| P/B | Limited | More useful for asset-heavy balance sheets than asset-light companies. |
| P/S | Limited | A revenue multiple lens when profit or FCF is not stable. |
| Peer Comparison | Not meaningful | Standardized peer comparisons are not included in the current version. |
Model calculation reference
Hover each model row to inspect formulas and inputs.
Current price282.90 USD
Model median referenceLimited model reference
Price vs model medianLimited model reference
Price date2026/05/01
The aggregated models are mostly limited-reference views, so the composite range bar is not shown.
Excluded
Owner Earnings
Uses net income, D&A, and capex as an owner-earnings proxy.
---
-Owner earnings samples are insufficient.
Excluded
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth-
-
-Positive free-cash-flow samples are insufficient.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
324.41 USD324.41 USD324.41 USD
-12.8%
324.41 USDCurrent price is 12.8% below the base model value.
Updated: 2026/05/03
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
FY2025 · Dec 2025 report14 records
Revenue275B USD
Net income6B USD
Free cash flow-
CapEx-
Operating cash flow10B USD
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
ExpandCollapse
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Business sale gain/loss | Asset sale gain/loss | -1B USD | Medium |
| 2024/12/31 | Business sale gain/loss | Asset sale gain/loss | 1B USD | Medium |
| 2024/12/31 | Restructuring charges | Restructuring | -216M USD | Medium |
| 2023/12/31 | Restructuring charges | Restructuring | -332M USD | Medium |
| 2023/12/31 | Severance costs | Restructuring | -183M USD | Medium |
| 2022/12/31 | Business sale gain/loss | Asset sale gain/loss | 3B USD | Medium |
| 2021/12/31 | Restructuring charges | Restructuring | -133M USD | Medium |
| 2021/12/31 | Severance costs | Restructuring | -86M USD | Medium |
| 2026/03/31 | Business sale gain/loss | Asset sale gain/loss | 9M USD | Medium |
| 2025/09/30 | Business sale gain/loss | Asset sale gain/loss | 92M USD | Medium |
| 2025/09/30 | Restructuring charges | Restructuring | -623M USD | Medium |
| 2025/06/30 | Business sale gain/loss | Asset sale gain/loss | 32M USD | Medium |
| 2025/06/30 | Restructuring charges | Restructuring | -374M USD | Medium |
| 2025/03/31 | Business sale gain/loss | Asset sale gain/loss | 32M USD | Medium |
| 2025/03/31 | Restructuring charges | Restructuring | -170M USD | Medium |
| 2024/09/30 | Business sale gain/loss | Asset sale gain/loss | -152M USD | Medium |
| 2024/06/30 | Business sale gain/loss | Asset sale gain/loss | -15M USD | Medium |
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 14
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 275B USD | 6B USD | 7B USD | - | 22.18 | 26.48 |
| 2024/12/31 | Annual | 247B USD | 3B USD | 2B USD | - | 12.12 | 8.25 |
| 2023/12/31 | Annual | 195B USD | 5B USD | 6B USD | - | 17.39 | 19.12 |
| 2022/12/31 | Annual | 181B USD | 7B USD | 3B USD | - | 21.3 | 10.69 |
| 2021/12/31 | Annual | 174B USD | 5B USD | 6B USD | - | 15.73 | 16.37 |
Data source and quality
Open to inspect field-level SEC EDGAR source, filing form, and derived notes.
SEC EDGAR
Data source and quality
Open to inspect field-level SEC EDGAR source, filing form, and derived notes.
FAQ
Quick notes on price-implied expectations, model differences, and source data.
What is Cigna Group's intrinsic value?
Cigna Group's intrinsic value on TickerVal is reviewed through DCF outputs, reverse DCF implied growth, EV/EBITDA, P/FCF, valuation assumptions, and financial trends from public filings.
How is CI valued on TickerVal?
TickerVal values CI by comparing intrinsic value models, DCF and reverse DCF assumptions, cash-flow multiples, earnings-power references, and reported financial trends.
What does the current stock price imply?
The reverse DCF view estimates the free-cash-flow growth path implied by the current stock price under stated discount-rate and terminal-growth assumptions.
Which valuation models are used?
TickerVal uses DCF, reverse DCF, Owner Earnings, EPV, Graham Number, EV/EBITDA, P/FCF, P/B, P/S, and other model references where the underlying data is available.
Is this investment advice?
No. TickerVal does not provide investment advice, ratings, price targets, or buy/sell recommendations.
Early supporter list
Get notified as TickerVal adds saved assumptions.
Join the research reference list for product updates, model notes, and transparent assumption workflows.
Ad placement